Encoded Therapeutics
Encoded Therapeutics is a clinical-stage biopharmaceutical company developing next-generation gene therapies for neurological disorders, translating precision genetic science into transformative genetic medicines. Its Genetic Medicines Product Engine supports a pipeline led by ETX101, an investigational AAV gene therapy for SCN1A-positive Dravet Syndrome, alongside additional research programs. Backed by GV, Menlo Ventures, and SoftBank Vision Fund, the company is added to the API Evangelist network as a life-sciences profile. As a clinical-stage therapeutics company it publishes no public developer API, SDK, or developer portal; this profile captures its identity for the network.
Encoded Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Gene Therapy, Biotechnology, and Genetic Medicine.
Kin Score
Resources
Company 1
The organization behind the API